Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 2 institutions in 1 country.
Karen G C B Bindels-de HeusDepartment of Pediatrics, Erasmus MC Sophia Children's Hospital, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0002-7887-5558
Doesjka A HagenaarDepartment of Pediatrics, Erasmus MC Sophia Children's Hospital, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.ORCID 0009-0004-9274-6316
Ilonka DekkerDepartment of Pediatrics, Erasmus MC Sophia Children's Hospital, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
Danielle C M van der KaayDepartment of Pediatric Endocrinology, Erasmus MC Sophia Children's Hospital, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0001-6408-1717
Gerthe F KerkhofDepartment of Pediatric Endocrinology, Erasmus MC Sophia Children's Hospital, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
Encore Expertise Center For AsENCORE Expertise Center for Neurodevelopmental Disorders, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
Ype ElgersmaENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0002-3758-1297
Marie-Claire Y de WitENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
Sabine E MousENCORE Expertise Center for Neurodevelopmental Disorders, Erasmus MC, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0002-9088-8095
Henriette A MollDepartment of Pediatrics, Erasmus MC Sophia Children's Hospital, University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
Erasmus MC · NLErasmus MC - Sophia Children’s Hospital · NL
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Angelman Syndrome (AS) is a rare genetic disorder caused by lack of maternal UBE3A protein due to a deletion of the chromosome 15q11.2-q13 region, uniparental paternal disomy, imprinting center defect, or pathogenic variant in the
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Hyperphagia, Growth, and Puberty in Children with Angelman Syndrome. · full record | Socratic